O-1191

O-1191
[[File:|frameless|220px|alt=|]]
INN
Drug class
Routes of administration	Oral
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status	Research chemical
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

O-1191 is a synthetic cannabinoid that has been studied for its potential effects on the endocannabinoid system. It is a derivative of the classical cannabinoid structure and has been used primarily in research settings to understand the pharmacological properties of cannabinoids.

Chemical Structure

O-1191 is structurally related to other cannabinoids, featuring a core structure that interacts with the cannabinoid receptors in the body. The specific modifications in O-1191's chemical structure are designed to enhance its selectivity and potency at these receptors.

Pharmacology

O-1191 acts as a potent agonist at the CB1 and CB2 receptors, which are part of the endocannabinoid system. This system plays a crucial role in regulating various physiological processes, including pain sensation, mood, appetite, and memory.

Mechanism of Action

The mechanism of action of O-1191 involves binding to the cannabinoid receptors, which are G-protein coupled receptors. Upon binding, O-1191 activates these receptors, leading to a cascade of intracellular events that modulate neurotransmitter release and influence various physiological responses.

Therapeutic Potential

Research into O-1191 has suggested potential therapeutic applications in areas such as pain management, neuroprotection, and the treatment of certain psychiatric disorders. However, as a research chemical, it is not approved for clinical use.

Research and Development

O-1191 is primarily used in preclinical studies to explore the effects of cannabinoid receptor activation. These studies help in understanding the broader implications of cannabinoid receptor modulation and in the development of new therapeutic agents.

Safety and Toxicology

As with many research chemicals, the safety profile of O-1191 is not fully established. Studies in animal models are ongoing to determine its potential toxicological effects and to assess its safety for future therapeutic use.

Legal Status

O-1191 is classified as a research chemical and is not approved for medical use. Its legal status may vary by country, and it is typically subject to regulations governing the use of experimental compounds.

Also see

• Cannabinoid receptor
• Endocannabinoid system
• Synthetic cannabinoids
• CB1 receptor
• CB2 receptor